In Vitro Fertilization (IVF) Market Analysis | 2022-2028
In Vitro Fertilization (IVF) Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028
The In Vitro Fertilization (IVF) Market is segmented by Reagent Type (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, and OVUM Processing Media), by Equipment Type (Imaging Systems, Sperm Separation Systems, Cabinets, OVUM Aspiration Pumps, Incubators, Micromanipulator Systems, Gas Analyzers and Others), by Cycle Type (Fresh Non-Donor IVF Cycles, Frozen Non-Donor IVF Cycles, Frozen Donor IVF Cycles, and Fresh Donor IVF Cycles), by End-User Type (Fertility Clinics & Surgical Centers, Hospitals & Research Laboratories, and Cryobanks) and by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others])
In Vitro Fertilization (IVF) Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
In vitro fertilization is defined as a type of assisted reproduction in which a women’s eggs and man’s sperm are combined outside of the body in a Petri/laboratory dish. In vitro fertilization is the most widely used method for assisted reproduction due to the usage of advanced technology and favorable reimbursement policies.
The in vitro fertilization (IVF) market is expected to grow at a CAGR of 9.29% during 2022-2028.
The in vitro fertilization (IVF) market is likely to reach to USD 1,256.35 million in 2028.
Technological advancements in IVF-assisted reproduction methods are a significant trend in the global market. The growth of the global IVF market is primarily driven by declining fertility rates, which can be attributed to factors such as stress, pollution, increased smoking rates, and obesity. Growing awareness about infertility and the availability of various treatment options are expected to create lucrative opportunities for players in the global In Vitro Fertilization market during the review period.
Europe region accounted for the largest market share and is likely to grow at a robust CAGR during the forecast period.
The key players operating in the IVF Market are-Cooper Surgical Inc. (The U.S.), Vitro Life (Sweden), Cook Medical Incorporated (The U.S.), Thermo Fisher Scientific (The U.S.), Irvine Scientific (The U.S.), Genea Limited (Australia), The Baker Company, Inc. (The U.S.), Kitazato Corporation (Japan), Esco Micro Pte Ltd (Singapore), EMD Serono (The U.S.), IVF Tech APS (Denmark), Rocket Medical (UK).